date,title,source
Oct-17-18,"Adam Hacker, PhD Joins Autolus as Senior Vice President for Regulatory Affairs and Quality",PR Newswire
Oct-30-18,Autolus Therapeutics to Present at the Jefferies 2018 London Healthcare Conference,PR Newswire
Nov-01-18,Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 60th ASH Annual Meeting,PR Newswire
Nov-23-18,Autolus Therapeutics Submits Fiscal Year 2018 Form 20-F,PR Newswire
Dec-03-18,Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes,PR Newswire
Dec-03-18,Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH,PR Newswire
Dec-20-18,Autolus Therapeutics to Join NASDAQ Biotechnology Index,PR Newswire
Jan-09-19,MoCo economic development officials plan satellite office in Boston,American City Business Journals
Jan-09-19,"London biotech firm planning new U.S. HQ, research facility in Rockville",American City Business Journals
Jan-14-19,"Biotech to create 170 jobs, invest $28M in new Rockville HQ",American City Business Journals
Jan-14-19,"Autolus Therapeutics Enters Lease with Alexandria Real Estate Equities, Inc. for Future Commercial-Scale Manufacturing Site and U.S. Headquarters",PR Newswire
Jan-16-19,Alexandria Fully Leases New Built-to-Suit Facility to Autolus,Zacks
Feb-19-19,Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial,PR Newswire
Feb-19-19,Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris,PR Newswire
Feb-21-19,"Autolus Therapeutics to Announce Financial Results for the Transition Period from October 1, 2018 to December 31, 2018 and Host Conference Call on February 25, 2019",PR Newswire
Feb-25-19,Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies,GlobeNewswire
Feb-25-19,"Autolus Therapeutics Reports Financial and Operational Results for the Transition Period from October 1 to December 31, 2018",PR Newswire
Mar-04-19,Autolus Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference,GlobeNewswire
Mar-04-19,Autolus Therapeutics to Present New Data on AUTO1 at the American Association of Cancer Research (AACR) Annual Meeting 2019,GlobeNewswire
Mar-07-19,"Autolus Therapeutics to Host R&D Day on March 26, 2019",GlobeNewswire
Mar-26-19,Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day,GlobeNewswire
Mar-29-19,Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019,PR Newswire
Mar-29-19,Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019,GlobeNewswire
Apr-01-19,Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR,PR Newswire
Apr-01-19,Initial Results from Autolus Therapeutics ALLCAR19 Phase 1/2 Trial in Adult Acute Lymphoblastic Leukemia Presented at the AACR Annual Meeting,GlobeNewswire
Apr-08-19,Autolus Announces Proposed Public Offering in the United States,GlobeNewswire
Apr-12-19,Autolus Therapeutics (AUTL) Catches Eye: Stock Jumps 5.6%,Zacks
